by rss feed | Jul 26, 2022 | biotechs, News, News Feeds, Semma, stem cells for diabetes, Vertex, ViaCyte, VX-880
When I’m asked about the most promising areas of stem cell clinical research, cell therapy for type I diabetes is near the top including work by a biotech called ViaCyte. Other firms are in the mix too, boosting the overall odds of success in the coming decade....
by rss feed | Jan 4, 2022 | Diabetes, News Feeds, Predictions, Vertex, ViaCyte
The last few years in the stem cell and regenerative medicine arena have been complicated in many ways. Variables like surging stem cell clinics and COVID have made predictions harder. Even so, trying to make predictions is useful and it’s fun to go over past...
